Genetically engineered mice for combinatorial cardiovascular optobiology

被引:0
|
作者
Lee, Frank K. [1 ]
Lee, Jane C. [1 ]
Shui, Bo [1 ]
Reining, Shaun [1 ]
Jibilian, Megan [1 ]
Small, David M. [2 ]
Jones, Jason S. [2 ]
Allan-Rahill, Nathaniel H. [2 ]
Lamont, Michael Re [2 ]
Rizzo, Megan A. [3 ]
Tajada, Sendoa [4 ,5 ]
Navedo, Manuel F. [6 ]
Santana, Luis Fernando [4 ,5 ]
Nishimura, Nozomi [2 ]
Kotlikoff, Michael, I [1 ]
机构
[1] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14850 USA
[2] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA
[3] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA
[4] Univ Calif Davis, Sch Med, Dept Physiol, Davis, CA 95616 USA
[5] Univ Calif Davis, Sch Med, Dept Membrane Biol, Davis, CA 95616 USA
[6] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA
来源
ELIFE | 2021年 / 10卷
基金
美国国家卫生研究院;
关键词
calcium imaging; optogenetics; imaging; Mouse; IN-VIVO; FUNCTIONAL-CHARACTERIZATION; NEURAL ACTIVITY; BLOOD-FLOW; EXPRESSION; CONDUCTION; CHANNELS; PROTEIN; MOUSE; MECHANISMS;
D O I
10.7554/eLife.67858; 10.7554/eLife.67858.sa1; 10.7554/eLife.67858.sa2
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Optogenetic effectors and sensors provide a novel real-time window into complex physiological processes, enabling determination of molecular signaling processes within functioning cellular networks. However, the combination of these optical tools in mice is made practical by construction of genetic lines that are optically compatible and genetically tractable. We present a new toolbox of 21 mouse lines with lineage-specific expression of optogenetic effectors and sensors for direct biallelic combination, avoiding the multiallelic requirement of Cre recombinase -mediated DNA recombination, focusing on models relevant for cardiovascular biology. Optogenetic effectors (11 lines) or Ca2+ sensors (10 lines) were selectively expressed in cardiac pacemaker cells, cardiomyocytes, vascular endothelial and smooth muscle cells, alveolar epithelial cells, lymphocytes, glia, and other cell types. Optogenetic effector and sensor function was demonstrated in numerous tissues. Arterial/arteriolar tone was modulated by optical activation of the second messengers InsP(3) (opto alpha 1AR) and cAMP (optoss2AR), or Ca2+-permeant membrane channels (CatCh2) in smooth muscle (Acta2) and endothelium (Cdh5). Cardiac activation was separately controlled through activation of nodal/conducting cells or cardiac myocytes. We demonstrate combined effector and sensor function in biallelic mouse crosses: optical cardiac pacing and simultaneous cardiomyocyte Ca2+ imaging in Hcn4(BAC)-CatCh2/Myh6-GCaMP8 crosses. These experiments highlight the potential of these mice to explore cellular signaling in vivo, in complex tissue networks.
引用
收藏
页数:25
相关论文
共 50 条
  • [1] Lymphomas in genetically engineered mice
    Taddesse-Heath, L
    Morse, HC
    PATHOLOGY OF GENETICALLY ENGINEERED MICE, 2000, : 365 - 381
  • [2] GENETICALLY ENGINEERED MICE TO BE MARKETED
    STINSON, S
    CHEMICAL & ENGINEERING NEWS, 1988, 66 (47) : 6 - 6
  • [3] Of Mice and Microflora: Considerations for Genetically Engineered Mice
    Treuting, P. M.
    Clifford, C. B.
    Sellers, R. S.
    Brayton, C. F.
    VETERINARY PATHOLOGY, 2012, 49 (01) : 44 - 63
  • [4] Congenital Hydrocephalus in Genetically Engineered Mice
    Vogel, P.
    Read, R. W.
    Hansen, G. M.
    Payne, B. J.
    Small, D.
    Sands, A. T.
    Zambrowicz, B. P.
    VETERINARY PATHOLOGY, 2012, 49 (01) : 166 - 181
  • [5] Mammary pathology of genetically engineered mice
    Howard B.
    Breast Cancer Research, 2 (1)
  • [6] Interpretation of phenotype in genetically engineered mice
    Doetschman, T
    LABORATORY ANIMAL SCIENCE, 1999, 49 (02): : 137 - 143
  • [7] Genetically engineered mice in drug development
    Livingston, JN
    JOURNAL OF INTERNAL MEDICINE, 1999, 245 (06) : 627 - 635
  • [8] Hepatic pathology in genetically engineered mice
    Dagli, MLZ
    Ward, JM
    Merlino, G
    Enomoto, A
    Maronpot, RR
    PATHOLOGY OF GENETICALLY ENGINEERED MICE, 2000, : 317 - 335
  • [9] The use of genetically engineered mice in immunodermatology
    Musette, P
    Gachelin, G
    EUROPEAN JOURNAL OF DERMATOLOGY, 1997, 7 (04) : 247 - 250
  • [10] Clinical evaluation of genetically engineered mice
    Devor-Henneman, DE
    PATHOLOGY OF GENETICALLY ENGINEERED MICE, 2000, : 145 - 154